Skip to Content

Join the 'Head and Neck Cancer' group to help and get support from people like you.

Head and Neck Cancer News

Related terms: Oral Cancer

Survival Continues to Improve for Most Cancers

Posted 31 Mar 2017 by Drugs.com

FRIDAY, March 31, 2017 – Overall cancer death rates in the United States continue to fall, but racial gaps persist, a new report says. Death rates fell between 2010 and 2014 for 11 of the 16 most common cancers in men and for 13 of the most common types in women, including lung, colon, prostate and breast cancers. However, death rates rose for cancers of the liver, pancreas and brain in men and for the liver and uterus in women. And improvements in cancer survival weren't equal for all Americans. "While this report found that five-year survival for most types of cancer improved among both blacks and whites over the past several decades, racial disparities for many common cancers have persisted, and they may have increased for prostate cancer and female breast cancer," said Dr. Lynne Penberthy. She's associate director of the U.S. National Cancer Institute's Surveillance Research ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Melanoma, Skin Cancer, Pancreatic Cancer, Ovarian Cancer, Endometrial Cancer, Osteosarcoma, Small Cell Lung Cancer, Breast Cancer - Adjuvant, Cervical Cancer, Bladder Cancer, Melanoma - Metastatic

Got the HPV Vaccine Before You Knew You Were Pregnant? Don't Worry

Posted 29 Mar 2017 by Drugs.com

WEDNESDAY, March 29, 2017 – The cancer-preventing HPV vaccine does not appear to have any ill effect on babies unintentionally exposed to it in the womb, researchers report. Babies whose mothers were vaccinated against human papillomavirus (HPV) during pregnancy did not have a significantly higher risk for major birth defects, low birth weight, preterm birth or stillbirth, compared with unexposed babies, according to a new study. "We found no support for an adverse effect on the unborn baby of HPV vaccination in pregnancy," said senior author Anders Hviid. Hviid is a senior investigator with the Statens Serum Institute in Copenhagen, Denmark. HPV is a sexually transmitted virus that's responsible for virtually all cases of cervical cancer, 95 percent of anal cancer and 70 percent of throat cancers, according to the U.S. National Cancer Institute. HPV vaccines are recommended for all ... Read more

Related support groups: Cancer, Gardasil, Cervical Cancer, Head and Neck Cancer, Cervarix, Human Papillomavirus Vaccine, Human Papillomavirus Prophylaxis, Vaccination and Prophlaxis, Gardasil 9

Cancer Survivors Gain From Web-Based Health Care

Posted 10 Feb 2017 by Drugs.com

FRIDAY, Feb. 10, 2017 – Online- and phone-based health care offers a number of benefits for cancer survivors, British researchers report. The new study looked at previous research on cancer survivors' experiences with online and phone health contacts – what the researchers call telehealth. The review found that patients liked the flexibility and convenience of this method of staying in touch with their care providers because they could do so in a familiar, comfortable setting and with minimum disruption to their lives. The perceived anonymity of telehealth reduced patients' sense of vulnerability and some said they were more comfortable raising concerns in this setting than in face-to-face appointments. Negative aspects of telehealth mentioned by patients included not being able to meet their health care providers in person, while other patients said they couldn't use the service due ... Read more

Related support groups: Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Skin Cancer, Ovarian Cancer, Small Cell Lung Cancer, Bladder Cancer, Cervical Cancer, Stomach Cancer, Head and Neck Cancer, Breast Cancer, Prevention, Testicular Cancer, Breast Cancer - Palliative, Zollinger-Ellison Syndrome, Wilms' Tumor, Solid Tumors

Can Breath Test Detect Stomach Cancers Earlier?

Posted 31 Jan 2017 by Drugs.com

TUESDAY, Jan. 31, 2017 – A breath test to detect stomach and esophageal cancers shows promise, researchers say. The test measures five chemicals in the breath. It was 85 percent accurate in detecting these cancers in more than 300 patients, the new study found. Each year, 1.4 million cases of cancer of the stomach and esophagus (the tube leading from the throat to the stomach) are diagnosed worldwide. Both tend to be diagnosed at a late stage and the five-year survival rate for the two cancers is 15 percent, the researchers said. Findings from the study were presented Monday at the European Cancer Congress (ECC). "At present the only way to diagnose esophageal cancer or stomach cancer is with endoscopy. This method is expensive, invasive and has some risk of complications," study author Dr. Sheraz Markar said in an ECC news release. Markar is from Imperial College London in England. ... Read more

Related support groups: Cancer, Head and Neck Cancer, Gastric Cancer, Diagnosis and Investigation, Salivary Gland Cancer, Head Imaging

Mental Health May Affect Chances Against Cancer

Posted 26 Jan 2017 by Drugs.com

WEDNESDAY, Jan. 25, 2017 – Anxiety and depression may increase the risk of death from certain cancers, early research suggests. After analyzing studies involving thousands of patients in Great Britain, researchers found that people with greater levels of psychological distress had higher death rates for colon, esophageal, pancreatic and prostate cancers and leukemia. The study was published Jan. 25 in the BMJ. "Our findings contribute to the evidence that poor mental health might have some predictive capacity for certain physical diseases, but we are a long way off from knowing if these relationships are truly causal," said researcher David Batty in a journal news release. Batty is with University College London. He and his colleagues reviewed 16 English and Scottish studies that included more than 163,000 people, aged 16 and older. The people were initially cancer-free and followed ... Read more

Related support groups: Depression, Anxiety, Anxiety and Stress, Major Depressive Disorder, Prostate Cancer, Colorectal Cancer, Dysthymia, Psychiatric Disorders, Pancreatic Cancer, Head and Neck Cancer

Artificial 'Voice Box' Implant Helps Cancer Patient Speak

Posted 5 Jan 2017 by Drugs.com

WEDNESDAY, Jan. 4, 2017 – An artificial "voice box" has provided long-term relief for a throat cancer patient in France The 56-year-old man can now speak with an intelligible whisper and breathe normally, said lead researcher Nihal Engin Vrana. The patient, who lives in Alsace, received the implant in 2015. He has lived well with it for longer than 16 months, said Vrana, vice president of Protip Medical, the French company that created the artificial larynx. "This is the first time a patient has had the implant long-term and resumed certain functions such as breathing and voice, thus considerably improving his quality of life," Vrana said. The patient also has a fully restored sense of smell, which had been compromised by removal of his larynx, researchers said. The larynx serves two main functions. It contains the vocal cords necessary for speech. The organ also features an upper ... Read more

Related support groups: Cancer, Head and Neck Cancer

Benign 'Toothlet' Tumor Found in 255 Million-Year-Old Fossil

Posted 8 Dec 2016 by Drugs.com

THURSDAY, Dec. 8, 2016 – A fossil of a distant ancestor of today's mammals – which include humans – shows evidence of a benign tumor of the jaw, scientists report. The finding pushes back by hundreds of millions of years the advent of these "toothlet" tumors, called odontomas, says a team from the University of Washington in Seattle. The researchers discovered the compound odontoma tumor in the fossilized jaw of a gorgonopsian, a precursor to mammals that lived 255 million years ago. The fossil was unearthed in Tanzania in 2007. Previously, the earliest known evidence of odontomas was in fossils of creatures living less than 1 million years ago. According to the research team, gorgonopsian were distant mammal relatives and the top predators in the pre-dinosaur Permian era when they existed. These animals ranged in size from 2 feet to 10 feet in length, and were known as the "saber ... Read more

Related support groups: Cancer, Head and Neck Cancer, Solid Tumors

Worldwide Cancer Rates Up More Than One-Third in Past Decade: Report

Posted 4 Dec 2016 by Drugs.com

SATURDAY, Dec. 3, 2016 – Cancer cases rose 33 percent worldwide in the past 10 years, a new study shows. In 2015, there were 17.5 million diagnoses and 8.7 million deaths in the world from the disease, the researchers found. The rise in cancer cases was mainly due to population aging and growth, along with changes in age-specific cancer rates, according to the Global Burden of Disease Cancer Collaboration study. The lifetime risk of developing cancer was one in three for men and one in four for women, the researchers said. Prostate cancer was the most common type of cancer in men (1.6 million cases), and tracheal, bronchus and lung cancer was the leading cause of cancer death in men. Breast cancer was the most common cancer for women (2.4 million cases), and the leading cause of cancer death in women. The most common cancers in children were leukemia, other neoplasms, non-Hodgkin ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Melanoma, Skin Cancer, Ovarian Cancer, Cervical Cancer, Head and Neck Cancer, Testicular Cancer, Salivary Gland Cancer, Solid Tumors

Could White Wine Boost Your Melanoma Risk?

Posted 1 Dec 2016 by Drugs.com

THURSDAY, Dec. 1, 2016 – A new study raises the possibility that people who enjoy a glass of white wine every day may face a slightly elevated risk of melanoma. Total alcohol intake was associated with a 14 percent higher risk of melanoma per drink per day, researchers found. But, when they looked at the type of alcohol consumed, white wine emerged as the potential culprit. Each drink per day of white wine was associated with a 13 percent higher risk of melanoma, the researchers said. "Per drink" risk was based on 12.8 grams of alcohol – the median amount of alcohol in a beer, a glass of wine or a shot of spirits. Beer, red wine and liquor did not significantly affect melanoma risk, the study authors added. The study does not prove that white wine causes this deadly skin cancer. It merely shows an association, though one worth exploring, the researchers said. "We are just adding one ... Read more

Related support groups: Cancer, Breast Cancer, Alcohol Dependence, Colorectal Cancer, Basal Cell Carcinoma, Melanoma, Skin Cancer, Alcoholism, Hangover, Melanoma - Metastatic, Squamous Cell Carcinoma, Head and Neck Cancer, Breast Cancer, Prevention, History - Skin Cancer, Acute Alcohol Intoxication

It's Never Too Late to Stop Smoking

Posted 30 Nov 2016 by Drugs.com

WEDNESDAY, Nov. 30, 2016 – You're never too old to reap the health benefits of quitting smoking, a new study finds. "Even participants who quit smoking as recently as in their 60s were 23 percent less likely to die during follow-up than those who continued to smoke into their 70s," said lead researcher Sarah Nash, who conducted the study while at the U.S. National Cancer Institute. In addition, the age at which you start smoking can have an impact on longevity, the researchers found. "This study confirms that age at smoking initiation and cessation, both key components of smoking duration, continue to be important predictors of mortality in U.S. adults over age 70," Nash said. "It also underscores the importance of measures to prevent initiation, as well as encourage cessation, for all smokers," she added. Nash is currently with the Alaska Native Epidemiology Center at the Alaska ... Read more

Related support groups: Cancer, Smoking, Smoking Cessation, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Stomach Cancer, Head and Neck Cancer

Cancer Advances Demand Continual Funding, Specialists Say

Posted 29 Nov 2016 by Drugs.com

TUESDAY, Nov. 29, 2016 – Sufficient and sustained funding for cancer research should be a global priority, European and American cancer organizations said at the start of an international oncology conference in Germany on Tuesday. Significant progress has been made in the understanding of how cancer develops. But, consistent research funding is needed to take advantage of these advances to improve cancer survival rates, according to specialists from two of the cancer organizations sponsoring the Munich meeting. "There has never been a more exciting time in cancer research," said Dr. Denis Lacombe, director general of the European Organisation for Research and Treatment of Cancer (EORTC). "With the surge in molecular biology developments and a growing consideration for cost-benefit balance from a public health perspective, there is an increasing need to invest in cancer research and ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Bladder Cancer, Cervical Cancer, Head and Neck Cancer

Bristol-Myers Squibb’s Opdivo (nivolumab) is the First Immuno-Oncology Treatment to Receive FDA Approval Based on Overall Survival in Head and Neck Cancer

Posted 14 Nov 2016 by Drugs.com

PRINCETON, N.J.--(BUSINESS WIRE) November 10, 2016 --Bristol-Myers Squibb Company (NYSE:BMY) announced today that the U.S. Food and Drug Administration (FDA) has approved Opdivo (nivolumab) injection, for intravenous use, for the treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) with disease progression on or after platinum-based therapy.1 Opdivo is the first and only Immuno-Oncology treatment proven in a Phase 3 trial to significantly extend overall survival (OS) for these patients.1 In oncology clinical trials, OS is considered the gold standard primary endpoint to evaluate the outcome of any therapy.3 The approval was based on results from the Phase 3, CheckMate -141 trial in which Opdivo demonstrated statistically significant and clinically meaningful superior OS vs the comparator arm (investigator’s choice of methotrexate, d ... Read more

Related support groups: Opdivo, Head and Neck Cancer, Nivolumab

A Doctor's Words Key to Whether Child Gets HPV Vaccine

Posted 2 Oct 2016 by Drugs.com

FRIDAY, Sept. 30, 2016 – The language doctors use when recommending the human papillomavirus (HPV) vaccine can influence whether parents will have their children immunized, a new study finds. HPV causes most cases of cervical cancer and a large percentage of vaginal, vulvar, anal, penile and oropharyngeal cancers. The U.S. Centers for Disease Control and Prevention recommends boys and girls receive the three-dose HPV vaccination beginning at age 11 or 12. As of 2015, only 42 percent of girls and 28 percent of boys ages 13 to 17 had completed the HPV vaccine series, according to the CDC. Previous research found that doctors' recommendations play a major role in whether parents have their children vaccinated. In this new study, researchers examined if specific language used by doctors affects parents' decisions. The study included more than 1,500 parents. Their children were between the ... Read more

Related support groups: Cancer, Human Papilloma Virus, Condylomata Acuminata, Gardasil, Cervical Cancer, Head and Neck Cancer, Human Papillomavirus Vaccine, Cervical Dysplasia, Cervarix, Human Papillomavirus Prophylaxis, Vaccination and Prophlaxis, Gardasil 9

More Cancer Patients Gaining From Immune-Based Treatments

Posted 20 Sep 2016 by Drugs.com

TUESDAY, Sept. 20, 2016 – A leading cancer group says more Americans are benefiting from immunotherapy – a relatively new treatment approach that helps the immune system target and destroy cancer cells. "The promise of immunotherapy for cancer therapy has never been greater, and the opportunity to make significant progress in this critical area is real," said Dr. Nancy Davidson, president of the American Association for Cancer Research (AACR). The AACR issued the news on immunotherapy as part of its 2016 Cancer Progress Report. As the group explained, more types of cancer are being successfully treated with immunotherapy. This treatment involves adding new cancer-fighting cells to the body or adding new elements, such as antibodies and proteins, to help the immune system fight cancer. In August 2015, one class of immunotherapy drugs – called checkpoint inhibitors – was approved for ... Read more

Related support groups: Lung Cancer, Non-Small Cell Lung Cancer, Melanoma, Opdivo, Bladder Cancer, Melanoma - Metastatic, Keytruda, Head and Neck Cancer, Hodgkin's Lymphoma, Nivolumab, Tecentriq, Pembrolizumab, Atezolizumab

Excess Weight Tied to Higher Risk for Many Cancers, Experts Say

Posted 25 Aug 2016 by Drugs.com

WEDNESDAY, Aug. 23, 2016 – Staying slim throughout your life might lower your risk of developing at least eight types of cancer, an international cancer research group says. Those include cancers of the stomach, liver, gallbladder, pancreas, ovary and thyroid. The list also includes a form of brain cancer known as meningioma, as well as a type of blood cancer called multiple myeloma. What's more, the latest research builds on the findings of an earlier review by the International Agency for Research on Cancer (IARC), which is part of the World Health Organization. That research found that those who avoid gaining weight can curtail their risk for developing five other types of cancer, including cancer of the colon, esophagus, kidney, breast and uterus. "The review certainly concluded crystal clear, as you say, that obesity causes cancer," noted Dr. Graham Colditz, who chaired the IARC ... Read more

Related support groups: Obesity, Cancer, Breast Cancer, Renal Cell Carcinoma, Colorectal Cancer, Head and Neck Cancer, Urinary Tract Cancer

Page 1 2 3 4 5 6 Next

Ask a Question

Further Information

Related Condition Support Groups

Salivary Gland Cancer, Cancer

Related Drug Support Groups

methotrexate, Opdivo, Taxotere, Keytruda, Erbitux, nivolumab, docetaxel, pembrolizumab, Methotrexate LPF Sodium, Trexall, cetuximab, Folex PFS